Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:13 pm Sale | 2022-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Point72 Asset Management, L.P. | 56,207 0.200% | -2,045,830 (-97.33%) | Filing History |
| 2023-02-14 4:13 pm Sale | 2022-12-31 | 13G | CytomX Therapeutics, Inc. CTMX | Point72 Asset Management, L.P. | 0 0.000% | -6,312,371 (Position Closed) | Filing History |
| 2023-02-14 4:12 pm Sale | 2022-12-31 | 13G | Chinook Therapeutics, Inc. KDNY | Point72 Asset Management, L.P. | 1,299,548 2.000% | -1,817,932 (-58.31%) | Filing History |
| 2023-02-14 4:12 pm Sale | 2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | Point72 Asset Management, L.P. | 10,673 0.100% | -1,653,394 (-99.36%) | Filing History |
| 2023-02-14 4:11 pm Sale | 2022-12-31 | 13G | Chimerix, Inc. CMRX | Point72 Asset Management, L.P. | 75,926 0.100% | -4,472,328 (-98.33%) | Filing History |
| 2023-02-14 4:11 pm Sale | 2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | Point72 Asset Management, L.P. | 368,006 0.700% | -2,052,303 (-84.80%) | Filing History |
| 2023-02-14 4:10 pm Sale | 2022-12-31 | 13G | Progress Acquisition Corp. PGRW | Point72 Asset Management, L.P. | 0 0.000% | -870,229 (Position Closed) | Filing History |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | Bicycle Therapeutics plc BCYC | Point72 Asset Management, L.P. | 1,021,168 3.400% | -551,655 (-35.07%) | Filing History |
| 2023-02-14 4:09 pm Sale | 2022-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Point72 Asset Management, L.P. | 73,946 2.200% | -89,158 (-54.66%) | Filing History |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | AxoGen, Inc. AXGN | Point72 Asset Management, L.P. | 1,864,583 4.400% | -247,080 (-11.70%) | Filing History |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Oyster Point Pharma, Inc. OYST | Point72 Asset Management, L.P. | 477 0.100% | -2,103,725 (-99.98%) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | BellRing Brands, Inc. BRBR | Point72 Asset Management, L.P. | 2,228,070 1.600% | 2,228,070 (New Position) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Otonomy, Inc. OTIC | Point72 Asset Management, L.P. | 0 0.000% | -5,450,000 (Position Closed) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Point72 Asset Management, L.P. | 8,647 0.200% | -176,719 (-95.34%) | Filing History |
| 2023-02-14 4:05 pm Sale | 2022-12-31 | 13G | Minerva Neurosciences, Inc. NERV | Point72 Asset Management, L.P. | 0 0.000% | -470,000 (Position Closed) | Filing History |
| 2023-02-14 4:04 pm Sale | 2022-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Point72 Asset Management, L.P. | 1,187,598 1.900% | -1,470,364 (-55.32%) | Filing History |
| 2023-02-14 4:04 pm Sale | 2022-12-31 | 13G | Merrimack Pharmaceuticals, Inc. MACK | Point72 Asset Management, L.P. | 0 0.000% | -900,981 (Position Closed) | Filing History |
| 2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | Applied Therapeutics, Inc. APLT | Point72 Asset Management, L.P. | 830,000 3.200% | -1,726,976 (-67.54%) | Filing History |
| 2023-02-14 4:03 pm Sale | 2022-12-31 | 13G | Mereo BioPharma Group plc MREO | Point72 Asset Management, L.P. | 22 0.100% | -10,609,978 (-100.00%) | Filing History |
| 2023-02-14 4:02 pm Sale | 2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO | Point72 Asset Management, L.P. | 115,484 0.200% | -1,644,764 (-93.44%) | Filing History |